Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-04-21

Clinical Trial Update: Botulinum Toxin in the Treatment of Raynaud's [NA]

View source ↗

Summary

A completed clinical trial evaluated botulinum toxin for Raynaud's syndrome; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin (botulinum toxin)

Snippet

Sponsor: Emory University | Conditions: Raynaud's Syndrome | NA | Status: COMPLETED | Results posted: 2014-04-21